دورية أكاديمية
Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study.
| العنوان: | Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study. |
|---|---|
| المؤلفون: | Sherman G; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School., Lamb GS; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School., Sharma TS; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School., Lloyd EC; Department of Pediatrics, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA., Nagel J; Department of Pharmacy, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA., Dandam NN; Department of Pharmacy, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA., Oliveira CR; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA., Sheikha HS; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA., Anosike BI; Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA., Lee P; Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA., Vora SB; Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA., Patel K; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Sue PK; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Rubbab B; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Yarbrough AM; Department of Pharmacy, Children's of Alabama, Birmingham, Alabama, USA., Ganapathi L; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School., Nakamura MM; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School.; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, MA, USA. |
| المصدر: | Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2023 Apr 18; Vol. 12 (3), pp. 152-155. |
| نوع المنشور: | Multicenter Study; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101586049 Publication Model: Print Cited Medium: Internet ISSN: 2048-7207 (Electronic) Linking ISSN: 20487193 NLM ISO Abbreviation: J Pediatric Infect Dis Soc Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Oxford : Oxford University Press |
| مواضيع طبية MeSH: | COVID-19*, Humans ; Child ; Retrospective Studies ; Antibodies, Monoclonal/therapeutic use ; Hospitalization ; Hospitals, Pediatric |
| مستخلص: | Monoclonal antibodies for COVID-19 are authorized in high-risk patients aged ≥12 years, but evidence in pediatric patients is limited. In our cohort of 142 patients treated at seven pediatric hospitals between 12/1/20 and 7/31/21, 9% developed adverse events, 6% were admitted for COVID-19 within 30 days, and none received ventilatory support or died. (© The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.) |
| التعليقات: | Comment in: J Pediatric Infect Dis Soc. 2023 Apr 18;12(3):156-158. doi: 10.1093/jpids/piad006. (PMID: 36928718) |
| References: | N Engl J Med. 2021 Jan 21;384(3):229-237. (PMID: 33113295) JAMA. 2021 Feb 16;325(7):632-644. (PMID: 33475701) N Engl J Med. 2021 Nov 18;385(21):1941-1950. (PMID: 34706189) Open Forum Infect Dis. 2021 Jul 24;8(8):ofab398. (PMID: 34409125) Open Forum Infect Dis. 2021 Jun 23;8(7):ofab331. (PMID: 34327256) N Engl J Med. 2021 Oct 7;385(15):1382-1392. (PMID: 34260849) |
| معلومات مُعتمدة: | K23 AI159518 United States AI NIAID NIH HHS; P30 AI060354 United States AI NIAID NIH HHS; UL1 TR001863 United States TR NCATS NIH HHS; K23AI159518 United States NH NIH HHS |
| فهرسة مساهمة: | Keywords: COVID-19; SARS-CoV-2; bamlanivimab and etesevimab; casirivimab and imdevimab; monoclonal antibodies; pediatric |
| المشرفين على المادة: | 0 (Antibodies, Monoclonal) |
| تواريخ الأحداث: | Date Created: 20230317 Date Completed: 20230420 Latest Revision: 20240616 |
| رمز التحديث: | 20240616 |
| مُعرف محوري في PubMed: | PMC10112679 |
| DOI: | 10.1093/jpids/piac124 |
| PMID: | 36928172 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!